Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Duration of Stimulation of Phagocytic Activity of the Reticulo-Endothelial System after Cessation of Treatment with Diethylstilbœstrol

Abstract

NICOL et al. have reported previously that diethylstilbœstrol is a strong stimulant of the phagocytic activity of the reticulo-endothelial system1. The present research was designed to ascertain the period of time during which the stimulative effect would persist after cessation of treatment with diethylstilbœstrol.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Nicol, T., Bilbey, D. L. J., and Ware, C. C., Nature, 181, 1538 (1958).

    Article  ADS  CAS  PubMed  Google Scholar 

  2. Biozzi, G., Benacerraf, B., and Halpern, B. N., Brit. J. Exp. Path., 34, 441 (1953).

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Nicol, T., and Ware, C. C., Nature, 185, 42 (1960).

    Article  ADS  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

WARE, C., NICOL, T. Duration of Stimulation of Phagocytic Activity of the Reticulo-Endothelial System after Cessation of Treatment with Diethylstilbœstrol. Nature 186, 974–975 (1960). https://doi.org/10.1038/186974a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/186974a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing